(Q36361890)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16396052%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

review article

1 reference

title

Relationship of C-reactive protein, metabolic syndrome and diabetes mellitus: potential role of statins (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16396052%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

David T Nash

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16396052%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

1 December 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16396052%20AND%20SRC:MED&resulttype=core&format=json

Journal of the National Medical Association

15 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16396052%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

97

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16396052%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16396052%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

1600-1607

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16396052%20AND%20SRC:MED&resulttype=core&format=json

C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis

15 January 2020

cites work

1 reference

12 December 2020

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

1 reference

12 December 2020

Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells.

1 reference

12 December 2020

Metabolic and inflammation variable clusters and prediction of type 2 diabetes: factor analysis using directly measured insulin sensitivity

1 reference

12 December 2020

The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).

1 reference

12 December 2020

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study

1 reference

12 December 2020

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

1 reference

12 December 2020

Incident type 2 diabetes mellitus in African American and white adults: the Atherosclerosis Risk in Communities Study.

1 reference

12 December 2020

Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design of the JUPITER trial

1 reference

12 December 2020

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

1 reference

12 December 2020

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

1 reference

12 December 2020

Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham Risk Scores

1 reference

12 December 2020

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

1 reference

12 December 2020

A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis

1 reference

12 December 2020

Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease

1 reference

12 December 2020

Relationships and CHD risks of BMI, lipoproteins, lipids, and blood pressure in African-American men and women

1 reference

12 December 2020

C-reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study).

1 reference

12 December 2020

Coming of age of C-reactive protein: using inflammation markers in cardiology

1 reference

12 December 2020

C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study

1 reference

12 December 2020

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

1 reference

12 December 2020

C-reactive protein stimulates MMP-1 expression in U937 histiocytes through Fc[gamma]RII and extracellular signal-regulated kinase pathway:: an implication of CRP involvement in plaque destabilization

1 reference

12 December 2020

Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators.

1 reference

12 December 2020

C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984-1998.

1 reference

12 December 2020

C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women

1 reference

12 December 2020

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

1 reference

12 December 2020

Effects of rosglitazone on plasma adiponectin, insulin sensitivity, and insulin secretion in high-risk African Americans with impaired glucose tolerance test and type 2 diabetes

1 reference

12 December 2020

The contribution of baseline weight and weight gain to blood pressure change in African Americans: the Pitt County Study

1 reference

12 December 2020

Direct proinflammatory effect of C-reactive protein on human endothelial cells

1 reference

12 December 2020

C-reactive protein levels and outcomes after statin therapy

1 reference

12 December 2020

Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells

1 reference

12 December 2020

The continuing epidemics of obesity and diabetes in the United States

1 reference

12 December 2020

Effects of rosuvastatin, atorvastatin, simvastatin, and pravastatin on atherogenic dyslipidemia in patients with characteristics of the metabolic syndrome

1 reference

12 December 2020

C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study

1 reference

12 December 2020

Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults

1 reference

12 December 2020

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

1 reference

12 December 2020

Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study

1 reference

12 December 2020

The effects of rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, on markers of endothelial cell activation, C-reactive protein, and fibrinogen levels in non-diabetic coronary artery disease patients

1 reference

12 December 2020

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

1 reference

12 December 2020

Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?

1 reference

12 December 2020

Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators

1 reference

12 December 2020

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

1 reference

12 December 2020

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

12 December 2020

Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus

1 reference

12 December 2020

SEROLOGICAL REACTIONS IN PNEUMONIA WITH A NON-PROTEIN SOMATIC FRACTION OF PNEUMOCOCCUS

1 reference

12 December 2020

Identifiers

1 reference